These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653 [TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in stage I epithelial ovarian cancer. Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662 [TBL] [Abstract][Full Text] [Related]
6. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Aletti GD; Dowdy S; Podratz KC; Cliby WA Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488 [TBL] [Abstract][Full Text] [Related]
7. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725 [TBL] [Abstract][Full Text] [Related]
13. Lymphatic spread among women with primary peritoneal carcinoma. Eltabbakh GH; Mount SL J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724 [TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089 [TBL] [Abstract][Full Text] [Related]
15. [Our and foreign experience in surgical staging of early ovarian cancer]. Ivanov C Akush Ginekol (Sofiia); 2011; 50(2):19-22. PubMed ID: 21913568 [TBL] [Abstract][Full Text] [Related]
16. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Eisenkop SM; Spirtos NM Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976 [TBL] [Abstract][Full Text] [Related]
17. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer. Camara O; Sehouli J Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971 [TBL] [Abstract][Full Text] [Related]
18. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718 [TBL] [Abstract][Full Text] [Related]
19. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135 [TBL] [Abstract][Full Text] [Related]
20. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]